These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma]. Zhao Y; Zhang X; Hui H Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424 [TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma. Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
6. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775 [TBL] [Abstract][Full Text] [Related]
7. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117 [TBL] [Abstract][Full Text] [Related]
9. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T Hepatology; 1995 Dec; 22(6):1838-46. PubMed ID: 7489996 [TBL] [Abstract][Full Text] [Related]
10. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
11. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Su H; Lu R; Ding R; Kan YW Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589 [TBL] [Abstract][Full Text] [Related]
13. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347 [TBL] [Abstract][Full Text] [Related]
15. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]. He J; Chen Y; Li H; Lu Y; Yan Y; Tan X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149 [TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene. Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840 [TBL] [Abstract][Full Text] [Related]
17. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line]. Huang H; Wang A Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726 [TBL] [Abstract][Full Text] [Related]
18. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene]. Gao G; Huang T; Chen S Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):301-3. PubMed ID: 12133366 [TBL] [Abstract][Full Text] [Related]
19. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
20. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]